(Q44584141)

English

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus

scientific article published on 17 November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bruce D. Walker

8

object named as

Bruce D Walker

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Eric S Rosenberg

3

object named as

Eric S Rosenberg

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Rajesh T Gandhi

1

object named as

Rajesh T Gandhi

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Alysse G Wurcel

2

object named as

Alysse Wurcel

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Mary N Johnston

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Nicholas Hellmann

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Michael Bates

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Martin S Hirsch

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

17 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1693-1698

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen.

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro

1 reference

https://api.crossref.org/works/10.1086%2F379773

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_l2p4ecfqzjh3phsrcdhiuntgia

1 reference

https://api.fatcat.wiki/v0/release/l2p4ecfqzjh3phsrcdhiuntgia

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44584141&oldid=2028652786"